PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ila Baiju Shah PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Baiju Mansukhlal PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ami Mihir Shah PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Allotment
Outcome of Board Meeting - Allotment of 29,80,750 warrants convertible into equity shares on preferential basis. PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended December 31, 2021.
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter ended 31st December, 2021 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after the conclusion of the Board meeting. Kindly acknowledge the receipt of the same and Oblige standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter ended 31st December, 2021 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after the conclusion of the Board meeting. Kindly acknowledge the receipt of the same and Oblige PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended December 31, 2021.
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter ended 31st December, 2021 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after the conclusion of the Board meeting. Kindly acknowledge the receipt of the same and Oblige PARNAX LAB LTD. - 506128 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Parnax Lab Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here PARNAX LAB LTD. - 506128 - Voting Results Under Regulation 44(3) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015 Along With The Scrutinizer'S Report
Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we submit herewith the Scrutiniser's Report of the remote e-voting and voting done through electronic means ("e-voting") on the resolutions contained in the notice dated January 1, 2022 ("Notice") calling Extra ordinary General Meeting of Its Equity Shareholders ("the Meeting"/"EGM") of the Company held on 31st January, 2022 at 11.00 a.m. through Video Conferencing/ Other Audio-Visual Means. PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations) read with Para A of Part A of Schedule III to the Listing Regulations, we hereby enclose the brief details about change in Memorandum of Association of the Company as approved at the Extra-Ordinary General Meeting of the Members of the Company held on Monday, January 31, 2022 at 11:00 A.M. through Video Conferencing / Other Audio-Visual Means (VC/0AVM) for your record. Kindly take the same on your record and Oblige Please Acknowledge the receipt of the same. PARNAX LAB LTD. - 506128 - Proceedings Of The Extra-Ordinary General Meeting (AGM) Of The Company Held On Monday, January 31, 2022 At 11:00 A.M.
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations) read with Para A of Part A of Schedule III to the Listing Regulations, we hereby enclose Proceedings of the Extra-Ordinary General Meeting of the Members of the Company held on Monday, January 31, 2022 at 11:00 A.M. through Video Conferencing / Other Audio-Visual Means (VC/0AVM) for your record. The meeting commenced at 11:03 A.M. and concluded at 11:32 A.M. (including time allowed for e-voting at AGM)